February 27, 2018 / 10:49 PM / in 4 months

BRIEF-Reata Provides Program Update On Phase 2 Rare Renal Clinical Trials

Feb 27 (Reuters) - Reata Pharmaceuticals Inc:

* REATA PROVIDES PROGRAM UPDATE ON PHASE 2 RARE RENAL CLINICAL TRIALS

* REATA PHARMACEUTICALS INC - FIRST DATA FROM PHOENIX EXPECTED 2H18 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below